243 related articles for article (PubMed ID: 22683420)
21. Combination antiangiogenic therapy and radiation in head and neck cancers.
Hsu HW; Wall NR; Hsueh CT; Kim S; Ferris RL; Chen CS; Mirshahidi S
Oral Oncol; 2014 Jan; 50(1):19-26. PubMed ID: 24269532
[TBL] [Abstract][Full Text] [Related]
22. Can gene editing and silencing technologies play a role in the treatment of head and neck cancer?
Shaikh MH; Clarke DTW; Johnson NW; McMillan NAJ
Oral Oncol; 2017 May; 68():9-19. PubMed ID: 28438299
[TBL] [Abstract][Full Text] [Related]
23. Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line.
Harris M; Wang XG; Jiang Z; Goldberg GL; Casadevall A; Dadachova E
Head Neck Oncol; 2011 Feb; 3(1):9. PubMed ID: 21314983
[TBL] [Abstract][Full Text] [Related]
24. Combined Transcriptome and Proteome Analysis of Immortalized Human Keratinocytes Expressing Human Papillomavirus 16 (HPV16) Oncogenes Reveals Novel Key Factors and Networks in HPV-Induced Carcinogenesis.
Yang R; Klimentová J; Göckel-Krzikalla E; Ly R; Gmelin N; Hotz-Wagenblatt A; Řehulková H; Stulík J; Rösl F; Niebler M
mSphere; 2019 Mar; 4(2):. PubMed ID: 30918060
[TBL] [Abstract][Full Text] [Related]
25. Applications of molecular diagnostics for personalized treatment of head and neck cancer: state of the art.
Mes SW; Leemans CR; Brakenhoff RH
Expert Rev Mol Diagn; 2016; 16(2):205-21. PubMed ID: 26620464
[TBL] [Abstract][Full Text] [Related]
26. Developments in therapeutic human papillomavirus vaccination.
Albers AE; Siniković B; Banko AV; Jovanović S; Kaufmann AM
Acta Chir Iugosl; 2009; 56(3):29-37. PubMed ID: 20218099
[TBL] [Abstract][Full Text] [Related]
27. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
28. Telomerase-specific virotherapy for human squamous cell carcinoma.
Fujiwara T
Expert Opin Biol Ther; 2009 Mar; 9(3):321-9. PubMed ID: 19216621
[TBL] [Abstract][Full Text] [Related]
29. Oncolytic viruses: a new paradigm for treatment of head and neck cancer.
Lott JB
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Feb; 113(2):155-60. PubMed ID: 22677730
[No Abstract] [Full Text] [Related]
30. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.
Patel KR; Chernock RD; Zhang TR; Wang X; El-Mofty SK; Lewis JS
Hum Pathol; 2013 Nov; 44(11):2385-92. PubMed ID: 24071016
[TBL] [Abstract][Full Text] [Related]
31. HPV-related squamous cell carcinoma of the head and neck: An update on testing in routine pathology practice.
Bishop JA; Lewis JS; Rocco JW; Faquin WC
Semin Diagn Pathol; 2015 Sep; 32(5):344-51. PubMed ID: 25724476
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring.
Paz IB; Cook N; Odom-Maryon T; Xie Y; Wilczynski SP
Cancer; 1997 Feb; 79(3):595-604. PubMed ID: 9028373
[TBL] [Abstract][Full Text] [Related]
33. [Genomic characterization of head and neck squamous cell carcinoma: Impact and challenges for therapeutic management].
Saada-Bouzid E; Milano G; Thariat J
Bull Cancer; 2018 Sep; 105(9):820-829. PubMed ID: 29937334
[TBL] [Abstract][Full Text] [Related]
34. Human Papillomavirus Associated Cancers of the Head and Neck: An Australian Perspective.
Aldalwg MAH; Brestovac B
Head Neck Pathol; 2017 Sep; 11(3):377-384. PubMed ID: 28176136
[TBL] [Abstract][Full Text] [Related]
35. Current status of experimental therapeutics for head and neck cancer.
Lee J; Moon C
Exp Biol Med (Maywood); 2011 Apr; 236(4):375-89. PubMed ID: 21427235
[TBL] [Abstract][Full Text] [Related]
36. The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus.
Ragin CC; Modugno F; Gollin SM
J Dent Res; 2007 Feb; 86(2):104-14. PubMed ID: 17251508
[TBL] [Abstract][Full Text] [Related]
37. Decreased plasma DEK Oncogene Levels Correlate with p16-Negative Disease and Advanced Tumor Stage in a Case-Control Study of Patients with Head and Neck Squamous Cell Carcinoma.
Wise-Draper T; Sendilnathan A; Palackdharry S; Pease N; Qualtieri J; Butler R; Sadraei NH; Morris JC; Patil Y; Wilson K; Mark J; Casper K; Takiar V; Lane A; Privette Vinnedge L
Transl Oncol; 2018 Feb; 11(1):168-174. PubMed ID: 29289845
[TBL] [Abstract][Full Text] [Related]
38. Therapy of head and neck squamous cell carcinoma with replicative adenovirus expressing tissue inhibitor of metalloproteinase-2 and chemoradiation.
McNally LR; Rosenthal EL; Zhang W; Buchsbaum DJ
Cancer Gene Ther; 2009 Mar; 16(3):246-55. PubMed ID: 18846112
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus therapeutic vaccines in head and neck tumors.
Badaracco G; Venuti A
Expert Rev Anticancer Ther; 2007 May; 7(5):753-66. PubMed ID: 17492938
[TBL] [Abstract][Full Text] [Related]
40. The potential for tumor suppressor gene therapy in head and neck cancer.
Birkeland AC; Ludwig ML; Spector ME; Brenner JC
Discov Med; 2016 Jan; 21(113):41-7. PubMed ID: 26896601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
